On Friday December 8th, 2023, amidst a rich end-of-year festive atmosphere, The Tartufo Restaurant in Boston was brightly lit and bustling with energy, filled with bursts of joyful laughter and cheers.
On that night, Biointron held a special customer appreciation party. This party is dedicated to appreciating new and existing clients for the long-standing support and trust, and to looking forward to further collaborations.
We were honored to invite a host of partners and peers to attend this party. Mr. Zha Changchun, the CEO of Biointron, delivered a heartfelt speech, expressing gratitude to all the guests in attendance and conveying his appreciation for the continued support from our partners and industry colleagues over the years.
At the same time, the SVP of R&D, Dr. Shi Lei, presented a detailed report on the company's current business progress. He also provided an outlook for the future, giving attendees a deeper understanding of the prospects for Biointron.
During the evening, Dr. Janice Reichert from The Antibody Society shared the latest research achievements and future development trends in the antibody industry. Her excellent presentation not only included the cutting-edge technologies of the industry but also provided an in-depth analysis and forecast of the future development of the antibody industry.
Boris Xu, Biointron’s International Business Development Director, along with all colleagues also attended the party, joining together for this unforgettable evening.
At the end of the event, Biointron’s representatives expressed heartfelt thanks to each guest and promised to continue striving in the new year to provide clients with high-quality, economic, and high-speed antibody services. This party was not just a business event but also a sincere gesture of appreciation and commitment, showcasing Biointron's celebration for our customers. We look forward to a better future together with you!
Antibody specificity refers to an antibody's ability to selectively bind to a unique epitope on a target antigen while avoiding interactions with unrelated antigens. This property arises from the highly specialized antigen-binding site located in the variable region of the antibody, which determines its unique binding characteristics.
Antibody affinity refers to the strength of the binding interaction between a single antigen epitope and the paratope (binding site) of an antibody. This interaction is a fundamental measure of how well an antibody recognizes its specific antigen target.
Recombinant antibodies are produced using genetic engineering techniques, unlike traditional antibody production, where the immune system generates antibodies without direct control over their sequence. By introducing genes encoding antibody fragments into host cells, such as bacteria or mammalian cells, recombinant antibodies can be expressed, purified, and deployed for applications including research, diagnostics, and therapeutics.
Recombinant antibody expression is a biotechnological process that involves engineering and producing antibodies outside their natural context using recombinant DNA technology.